PT1037629E - Combinacao de um ramba e um tocoferol - Google Patents

Combinacao de um ramba e um tocoferol

Info

Publication number
PT1037629E
PT1037629E PT98966615T PT98966615T PT1037629E PT 1037629 E PT1037629 E PT 1037629E PT 98966615 T PT98966615 T PT 98966615T PT 98966615 T PT98966615 T PT 98966615T PT 1037629 E PT1037629 E PT 1037629E
Authority
PT
Portugal
Prior art keywords
combination
tocoferol
ramba
concerned
present
Prior art date
Application number
PT98966615T
Other languages
English (en)
Inventor
Walter Boudewijn Leopo Wouters
De Porre Peter Marie-Zo Robert
Bruynseels Jan Paul Joz Michel
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PT1037629E publication Critical patent/PT1037629E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT98966615T 1997-12-19 1998-12-12 Combinacao de um ramba e um tocoferol PT1037629E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97204019 1997-12-19
PCT/EP1998/008127 WO1999032098A2 (en) 1997-12-19 1998-12-12 Combination of a ramba and a tocopherol

Publications (1)

Publication Number Publication Date
PT1037629E true PT1037629E (pt) 2005-03-31

Family

ID=8229088

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98966615T PT1037629E (pt) 1997-12-19 1998-12-12 Combinacao de um ramba e um tocoferol

Country Status (11)

Country Link
US (1) US6265425B1 (pt)
EP (1) EP1037629B1 (pt)
JP (1) JP2001526215A (pt)
AT (1) ATE280578T1 (pt)
AU (1) AU2413399A (pt)
DE (1) DE69827295T2 (pt)
DK (1) DK1037629T3 (pt)
ES (1) ES2232034T3 (pt)
PT (1) PT1037629E (pt)
SI (1) SI1037629T1 (pt)
WO (1) WO1999032098A2 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US7636680B2 (en) * 2001-10-03 2009-12-22 Starmine Corporation Methods and systems for measuring performance of a security analyst
TWI324518B (en) 2001-12-19 2010-05-11 Nektar Therapeutics Pulmonary delivery of aminoglycosides
US8309562B2 (en) 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
CN1984660B (zh) * 2003-07-03 2010-12-15 美瑞德生物工程公司 作为天冬氨酸特异性半胱氨酸蛋白酶活化剂和细胞程序死亡诱导剂的4-芳基氨基-喹唑啉
US8258145B2 (en) * 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
EP1833482A4 (en) 2005-01-03 2011-02-16 Myriad Genetics Inc COMPOUNDS AND ITS THERAPEUTIC USE
WO2007084542A2 (en) 2006-01-17 2007-07-26 Barrier Therapeutics, Inc. Treatment of inflammatory disorders with triazole compounds
JP2009527560A (ja) * 2006-02-21 2009-07-30 アムゲン インコーポレイティッド ホスホジエステラーゼ１０阻害剤としてのシンノリン誘導体
JPWO2009051213A1 (ja) * 2007-10-19 2011-03-03 国立大学法人 東京大学 白斑治療剤および色素沈着促進方法

Also Published As

Publication number Publication date
ATE280578T1 (de) 2004-11-15
DE69827295T2 (de) 2006-02-09
WO1999032098A3 (en) 1999-08-19
DK1037629T3 (da) 2005-03-07
EP1037629A2 (en) 2000-09-27
EP1037629B1 (en) 2004-10-27
SI1037629T1 (en) 2005-04-30
ES2232034T3 (es) 2005-05-16
WO1999032098A2 (en) 1999-07-01
DE69827295D1 (de) 2004-12-02
JP2001526215A (ja) 2001-12-18
US6265425B1 (en) 2001-07-24
AU2413399A (en) 1999-07-12

Similar Documents

Publication Publication Date Title
TR200000129T2 (tr) Yepyeni spiroazabisiklik heterosiklik bileşikler.
BR0012136A (pt) Inibidores de reabsorção de norepinefrina altamente seletivos e métodos de uso dos mesmos
NO20042596L (no) Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1
DK0650483T3 (da) (3R,4R)-Delta6-tetrahydrocannabinol-7-syrer
TR199901174T2 (xx) Yeni heterosiklilmetil-ikameli pirazol t�revleri.
MXPA04004837A (es) Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1.
SE0001899D0 (sv) New compounds
BR0315296A (pt) Derivados do ciclohexanol espirocìclicos
AU7031500A (en) Therapeutic quinazoline compounds
EP0249735A3 (en) Pharmaceutical preparations comprising as active agent 2-phenyl-1.2-benzisoselenazol-3(2h)-one, for the treatment of diseases caused by oxidative stress
PT1037629E (pt) Combinacao de um ramba e um tocoferol
MY124146A (en) Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
TW362973B (en) Use of 2-anino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazole as a composition having an antidepressant activity
MXPA04005007A (es) Prenda absorbente con ingredientes para bienestar de la piel incorporados.
BR0210013A (pt) Gel oftálmico de pirenzepina
HUP9802971A1 (hu) Az MMP-inhibitorok alkalmazása a szemben történő érképződés kezelésére
WO1987007835A1 (en) Drug for treatment and prophylaxis of kidney and liver diseases
RS44204A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
DK0988302T3 (da) Benzonaphthyridiner
HUP9801924A2 (hu) Nátrium/hidrogén-csere inhibitorokat és szív- és keringési zavarok kezelésére alkalmas hatóanyagokat tartalmazó gyógyszerkészítmény
DE60128100D1 (de) Analgetisches arzneimittel
CA2203463A1 (fr) Nouveaux acides et esters de la diosmetine, et les compositions pharmaceutiques les contenant
RS44304A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
NO20023111L (no) Utvortes preparat for behandling av pruritus
AU7935887A (en) Therapeutic agent for the treatment of peptic ulcer disease